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Decreased serotonergic activity has been implicated in anxiety and major depression,
and antidepressants directly or indirectly increase the long-term activity of the serotonin
system. A key component of serotonin circuitry is the 5-HT1A autoreceptor, which
functions as the major somatodendritic autoreceptor to negatively regulate the “gain”
of the serotonin system. In addition, 5-HT1A heteroreceptors are abundantly expressed
post-synaptically in the prefrontal cortex (PFC), amygdala, and hippocampus to mediate
serotonin actions on fear, anxiety, stress, and cognition. Importantly, in the PFC 5-HT1A
heteroreceptors are expressed on at least two antagonist neuronal populations: excitatory
pyramidal neurons and inhibitory interneurons. Rodent models implicate the 5-HT1A
receptor in anxiety- and depression-like phenotypes with distinct roles for pre- and
post-synaptic 5-HT1A receptors. In this review, we present a model of serotonin-PFC
circuitry that integrates evidence from mouse genetic models of anxiety and depression
involving knockout, suppression, over-expression, or mutation of genes of the serotonin
system including 5-HT1A receptors. The model postulates that behavioral phenotype
shifts as serotonin activity increases from none (depressed/aggressive not anxious)
to low (anxious/depressed) to high (anxious, not depressed). We identify a set of
conserved transcription factors including Deaf1, Freud-1/CC2D1A, Freud-2/CC2D1B and
glucocorticoid receptors that may confer deleterious regional changes in 5-HT1A receptors
in depression, and how future treatments could target these mechanisms. Further studies
to specifically test the roles and regulation of pyramidal vs. interneuronal populations
of 5-HT receptors are needed better understand the role of serotonin in anxiety and
depression and to devise more effective targeted therapeutic approaches.
Keywords: anxiety, depression, interneurons, pyramidal neurons, prefrontal cortex, raphe nuclei, serotonin
receptors, transcription factors
INTRODUCTION
DEPRESSION AND ANXIETY: ROLES OF SEROTONIN AND PREFRONTAL
CORTEX (PFC)
Depression and anxiety are complex and heterogeneous disor-
ders with a global disease burden that is steadily increasing and
has currently surpassed most other major diseases (Whiteford
et al., 2013). Their onset occurs during childhood to adoles-
cence persisting throughout lifetime. Depression and anxiety are
often comorbid and display a relapsing and remitting course that
becomes resistant to pharmacologic treatment (Gorwood, 2004;
Trivedi et al., 2006; Krishnan and Nestler, 2008; Rush et al., 2009).
Depression is complex in part because the diagnostic criteria do
not distinguish between different behavioral facets of depression,
hence very different subsets of depressed patients are “lumped”
together (Krishnan and Nestler, 2008). Nevertheless, twin stud-
ies demonstrate a clear genetic component, and a large number
of studies have implicated gene x environment interactions as
a key determinant of depression primates (Caspi et al., 2010).
Prominently adverse, stressful environment in early post-natal
or adolescent life increases the likelihood of depression and the
strength of association of genetic variant with depression.
Several lines of evidence implicate decreased serotonergic
activity in anxiety andmajor depression, but its importance in the
etiology and severity of these disorders remains unclear (Millan,
2004; Wong et al., 2005; Jans et al., 2007; aan het Rot et al., 2009;
Booij et al., 2010). Acute tryptophan depletion studies support a
role for decreased serotonin in depression, or at least in relapse of
recovered depressed patients (Barnes and Sharp, 1999; Young and
Leyton, 2002; Jans et al., 2007; Lanfumey et al., 2008; aan het Rot
et al., 2009). Imaging and post-mortem studies indicate altered
activity of discrete regions within the prefrontal cortex (PFC) and
their atrophy are associated with depression (Rajkowska et al.,
2005; Ressler and Mayberg, 2007). Genetic polymorphisms in
serotonin genes [e.g., 5-HT transporter (5-HTT), 5-HT1A recep-
tor] have been associated with depression, but these associations
are weak and not always reproducible, suggesting that serotonin
may be a predisposing factor rather than a cause of depression
or anxiety (Karg et al., 2011; Kishi et al., 2013). The mainstay
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of pharmacological treatment targets serotonin and/or other
monoamine systems, but these approaches have very modest
treatment effects and initial monotherapy with serotonin-specific
reuptake inhibitor (SSRI) is ineffective to achieve sustained remis-
sion in a majority of patients (Trivedi et al., 2006; Rush et al.,
2009). More recently the finding that ketamine can induce rapid
antidepressant effect coincident with remodeling and spine devel-
opment in the PFC suggest a key role for the PFC in depression
and its treatment (Aan Het Rot et al., 2012; Duman and Li,
2012). Deep brain stimulation of discrete sites within the PFC
has elicited remarkable improvement in depression symptoms in
some depressed patients, supporting the key role for hypo/hyper-
activity of different regions of the PFC in depression (Ressler and
Mayberg, 2007; Holtzheimer and Mayberg, 2011). Interestingly,
the beneficial effects of deep brain stimulation in animal models
of depression depend on 5-HT, indicating a primary role of the
5-HT-PFC circuitry in effective treatment of depression (Hamani
and Nobrega, 2012). In this review, we focus on the role of pre-
and post-synaptic 5-HT1A receptors in regulating the activity of
this circuitry, and on the behavioral outcomes of modifying this
circuitry.
THE SEROTONIN SYSTEM: ROLES OF PRE- AND POST-SYNAPTIC
RECEPTORS
The brain serotonin system consists of a small group of neu-
rons located in the raphe nuclei of the midbrain that are unique
since they express the rate-limiting enzyme for serotonin synthe-
sis, tryptophan hydroxylase-2 (TPH2), the brain specific isoform
Walther et al., 2003; Lenicov et al., 2007). The differentiation of
neuronal progenitors to express serotonergic markers like TPH2
is driven by the transcription factor Pet-1, which directly acti-
vates the TPH2 gene (Hendricks et al., 2003). 5-HT neurons of
the rostral raphe nuclei, including the dorsal and median raphe
nuclei, project widely throughout the brain to innervate key brain
regions involved in anxiety and depression. Activation of sero-
tonin neurons induces release of serotonin at target neurons
and within the raphe via collateral branches (Kocsis et al., 2006;
Bang et al., 2012), which is rapidly removed by the 5-HTT, the
target of SSRI antidepressants. Serotonin released in the raphe
activates the 5-HT1A autoreceptor, which negatively regulates
the firing of serotonin system. Release of serotonin at target
neurons activates 5-HT heteroreceptors including the 5-HT1A
heteroreceptor which is abundantly expressed in the hippocam-
pus, septum, amygdala, and PFC (Albert et al., 1990) where it
mediates serotonin actions on fear, anxiety, stress, and cognitive
function (Barnes and Sharp, 1999; Gross and Hen, 2004; Savitz
et al., 2009; Meltzer et al., 2012; Donaldson et al., 2013; Garcia-
Garcia et al., 2013). Since the 5-HT1A receptor is coupled to
inhibitory Gi/Go proteins (Barnes and Sharp, 1999; Albert and
Tiberi, 2001), it inhibits the firing and activity of target neurons
(Celada et al., 2004; Puig and Gulledge, 2011; Llado-Pelfort et al.,
2012). The other major 5-HT receptor (particularly in cortex)
is the Gq-coupled 5-HT2A receptor, which mediates excitatory
actions of serotonin on target neurons (Celada et al., 2004; Puig
and Gulledge, 2011; Llado-Pelfort et al., 2012). Thus in terms
of neural circuitry, the 5-HT1A receptor is inhibitory, while the
5-HT2A receptor is stimulatory. However, these receptors can also
couple to protein kinase pathways in a cell-specific manner that
may stimulate gene transcription and indirectly enhance neuronal
function in the long term (Kushwaha and Albert, 2005; Mogha
et al., 2012). For the purpose of clarity, we focus on the 5-HT1A as
the major inhibitory receptor and 5-HT2A as the major stimula-
tory receptor in PFC, although there are complementary roles for
other stimulatory 5-HT receptors in PFC, such as 5-HT3, 5-HT4,
and 5-HT7 receptors (Beique et al., 2004).
TARGETED GENETIC MODIFICATION OF THE SEROTONIN
SYSTEM AND BEHAVIOR
TRANSGENIC AND KNOCKOUT APPROACHES
Several mouse models have targeted the 5-HT1A receptor gene
or genes involved in determining 5-HT levels or 5-HT neuro-
transmission in the brain (Table 1) (Jacobsen et al., 2012a; Lesch
et al., 2012; Donaldson et al., 2013). More recently these studies
have included conditional and inducible knockout or suppression
approaches summarized in Box 1. Gene knockout approaches
result in irreversible loss of gene function, while inducible sup-
pression or expression approaches allow for reversible expression.
Inducible expression of CRE (for inducible knockout) has mainly
been done use the CRE-ERT2 construct, which is activated by
tamoxifen treatment. Inducible suppression has been done using
a doxycycline-suppressible repressor construct (Tanaka et al.,
2010). By the use of tissue-specific promoters, these approaches
can target specifically serotonin neurons (using Pet-1 or TPH2
promoters) or forebrain regions (usually CAMKIIα promoter).
The Pet-1/TPH2 promoters have been used to drive expression
of CRE recombinase in all midbrain serotonin neurons from the
initiation of their differentiation, with TPH2 driving somewhat
stronger expression. On the other hand, the CAMKII promoter
drives expression starting at the early post-natal period and is
widely expressed in glutamatergic pyramidal neurons of the fore-
brain but excluded from interneurons (Xu et al., 2000; Chen et al.,
2010). Together, these approaches provide both region- and cell
type-specific gene targeting that can be induced or reversed at
different developmental times.
RODENT BEHAVIORAL READOUTS OF ANXIETY, DEPRESSION AND
AGGRESSION
These rodent genetic models have been examined for 5-HT
neurotransmission and for anxiety, depression, and aggression-
related behaviors using a standard set of assays (Table 1). Anxiety
behavior has been typically assayed using elevated plus maze
(Lister, 1987), light-dark box, open field tests (Bouwknecht et al.,
2004; Crawley, 2008), which measure acute anxiety-like behav-
ior. In some cases novelty-suppressed feeding assay, which has
greater face validity since it responds to chronic and not acute
SSRI treatment (Santarelli et al., 2003). Depression-like behavior
has mainly been studied using acute tests like tail suspension (Liu
and Gershenfeld, 2003) or forced swim tests (Porsolt et al., 1977;
Castagne et al., 2009). These tests measure acute depression or
behavioral despair in an inescapable stress and are used to identify
antidepressant compounds. In a few cases, the sucrose preference
test has been done to assess anhedonia (Krishnan et al., 2008).
Aggression has been evaluated using the resident-intruder test,
and social interaction with animal vs. object or novel animal was
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Table 1 | 5-HT genetic models summary.
Genetic model Target gene expression Adult behavior References
Embryo (%) Early PN (%) Adult (%)
5-HT1A
5-HT1A−/− − – − Anxiety, antidepressed Heisler et al., 1998; Parks et al.,
1998; Ramboz et al., 1998
5-HT1A auto-iS (Pet1-tTX) + + −30 Antidepressed, SSRI+ Richardson-Jones et al., 2010
5-HT1A auto-iS (Pet1-tTX) + −40 + Anxiety, social− Donaldson et al., 2014
5-HT1A auto-iS (Pet1-tTX) −80 −80 −80 Anxiety Richardson-Jones et al., 2011
5-HT1A hetero-iS
(CamKII-tTX)
−95 −95 −95 Depression Richardson-Jones et al., 2011
5-HT1A auto-siRNA + + −80 Anti-depressed, SSRI+ Bortolozzi et al., 2012; Ferres-Coy
et al., 2013
5-HT1A hetero-rescue
(CaMKII-tTA iTg)
− + − Anti-anxiety Gross et al., 2002
5-HT1A-heteroOE
(5-HT1A-tg)
+ ++ + Anti-anxiety, Anti-depressed Kusserow et al., 2004
5-HT1A-autoOE (Tph2-tg) +300 +300 +300 Aggression, anxiety Audero et al., 2013; Piszczek
et al., 2013
5-HT1A-auto rescue
(Tph2-tg)
+300 +300 +300 Anxiety, anti-depressed Audero et al., 2013; Piszczek
et al., 2013
5-HT
TPH2−/− − – − Anti-Anxiety, depression, aggression Mosienko et al., 2012
TPH2-R439H KI −80 −80 −80 Anxiety, depression Jacobsen et al., 2012b; Sachs
et al., 2013
PET1−/− −80 −80 −80 Aggression, anxiety Hendricks et al., 2003
Pet1-adult-iKO + + −80 Anxiety Liu et al., 2010
En1/Pet1-TetTX IT −* −* −* Anti-Anxiety, cognitive+ Kim et al., 2009
5-HTT
5-HTT-/- − – − Anxiety, depression anti-aggression Holmes et al., 2002, 2003; Lira
et al., 2003; Kalueff et al., 2006
5-HTT-FLX + − + Anxiety Ansorge et al., 2004
5-HTT-G56A KI + + * + + * + + * Social−, SSRI+ Veenstra-Vanderweele et al., 2012
5-HTT-tg +100 +100 +100 Anti-anxiety Jennings et al., 2006
Genetic models are as defined in Box 1 with promoter used indicated in parentheses; rescue is expression in knockout background, over-expression (OE) is on
wild-type background; auto, autoreceptor-specific; hetero, heteroreceptor-specific. The effect of the indicated genetic model on target gene expression (−, none; +,
normal; ++, increased; +X, increased by X%) at indicated developmental time [embryo, early post-natal (PN) or adult] and adult behavior phenotype or response to
SSRI are indicated. *loss of 5-HT release; enhanced activity 5-HTT mutant.
quantified. These tests assess limited phenotypes compared to the
more complex phenotypes of anxiety disorders or major depres-
sion in humans. Thus the circuitry models presented below are in
the context of these assays of anxiety- or depression-like behav-
ior that may correspond to discrete endophenotypes of anxiety
disorder or depression in humans.
SEROTONIN-PFC CIRCUITRY IN ANXIETY AND DEPRESSION
RODENT MODELS
SEROTONIN-PFC CIRCUITRY MODEL IN THE ANXIETY PHENOTYPE
Comparing different genetic models, the effects of modifica-
tions of the serotonin system on anxiety behavior may often
appear paradoxical or in conflict (Table 1), but can be in part
accounted for by the model of 5-HT-PFC circuitry presented
in Figure 1. This model takes into account that there are two
major sub-populations of heteroreceptors in the PFC: 5-HT1A
receptors on pyramidal glutamatergic neurons that inhibit their
activity; and 5-HT1A receptors on interneurons that reduce
inhibition to enhance pyramidal neuron activity (Amargos-
Bosch et al., 2004; Santana et al., 2004). Immunostaining has
identified 5-HT1A receptors on human pyramidal axon ini-
tial segment and parvalbumin positive chandelier cells in layer
II/III (DeFelipe et al., 2001); pyramidal neurons in layer 2
tree shrew (Palchaudhuri and Flugge, 2005). 5-HT1A receptor
RNA is present in 80% of glutamatergic neurons in external
layers II and upper III, and in around 50% in layer VI (de
Almeida and Mengod, 2008). Electrophysiological studies show
presence of 5-HT1A receptors in pyramidal and interneurons,
the latter mediating inhibition of pyramidal activity (Amargos-
Bosch et al., 2004; Santana et al., 2004). In cortical neurons,
5-HT1A receptor activation inhibits NMDA currents (Yuen et al.,
2008), and reduces CAMKII-induced AMPA phosphorylation
(Cai et al., 2002), resulting in an inhibition of neuronal
activity.
Frontiers in Behavioral Neuroscience www.frontiersin.org June 2014 | Volume 8 | Article 199 | 3
Albert et al. Serotonin-PFC circuitry in anxiety and depression
Box 1 | List of genetic manipulations.
Genetic models presented in Table 1 are summarized below
Transgenic (Tg): Promoter-gene; Promoter dependent expression of gene; non-reversible
Knockout (KO, −/−): Gene disrupted; ubiquitous; lifetime; non-reversible
Conditional KO (cKO): flx-gene-flx X Promoter-CRE: Gene disrupted in CRE-expressing cells only; promoter-dependent onset; non-
reversible
Conditional induction: flx-STOP-flx-gene X Promoter-CRE: Gene induced in CRE-expressing cells; promoter-dependent onset; non-
reversible
Inducible Knockout (iKO): flx-gene-flx X Promoter-CRE-ERT2: Gene disrupted upon treatment (tamoxifen) in CRE-expressing cells only;
age-specific; non-reversible
Inducible Transgenic (iTg): TetO-KI-gene X Promoter-tTA; Promoter- and doxycycline regulated expression of gene; tissue-specific;
promoter-dependent onset; reversible with doxycycline
Inducible Suppression (iS): TetO-KI-geneI X Promoter-tetR-KRAB; Promoter- and doxycycline regulated suppression of gene; tissue-
specific; promoter-dependent onset; reversible with doxycycline treatment
Knockin (KI): Recombination of mutant gene for w.t.; normal gene expression pattern retained; non-reversible
Intersectional Transgenic (IT): flx-STOP-flx-flp-STOP2-flp-gene x promoter1-CRE x promoter2-FLP: gene expression dependent on inter
section of promoters 1 and 2; promoter-dependent onset; non-reversible
siRNA suppression: siRNA depletes target gene; can be targeted to 5-HT neurons by fusion to SSRI; reversible within few days.
Critical aspects of the serotonin circuit model in anxiety
(Figure 1) are:
• The hypothesized greater sensitivity of 5-HT1A receptors
on interneurons compared to relatively lower sensitivity of
5-HT1A receptors on glutamatergic pyramidal neurons that
mediate the anxiety phenotype;
• the greater activity of 5-HT2A vs. 5-HT1A receptors located
on pyramidal neurons during the early post-natal period com-
pared to adult (Beique et al., 2004) that once activated 5-HT2A
receptors antagonize 5-HT1A signaling and stimulate gluta-
matergic output (Celada et al., 2004; Puig and Gulledge, 2011;
Llado-Pelfort et al., 2012);
• increasing activity of this pyramidal projection increases
anxiety.
The evidence for a role of 5-HT1A receptors on interneurons is
mainly from systemic agonist (8-OHDPAT) administration stud-
ies in anaesthetized rats: DPAT reduces interneuron firing and
increases pyramidal cell firing (blocked by GABAzine) (Llado-
Pelfort et al., 2012). Pharmacological depletion of endogenous
5-HT in PFC to 5% of normal, reduced pyramidal firing from
about 2Hz to 1Hz, suggesting that interneuronal 5-HT1A inhi-
bition may play the predominate role in pyramidal activity under
basal anaesthetized conditions. However, the role of pyramidal vs.
interneuron 5-HT1A receptors in pyramidal firing activity needs
to be tested in awake behaving conditions using specific blockade
or knockout of these subpopulations of 5-HT1A receptors. There
is also evidence for a developmental switch in 5-HT-induced
responses in pyramidal neurons (Beique et al., 2004). Although
5-HT2A receptors have 10-fold lower affinity for 5-HT, in early
post-natal development 5-HT excites PFC pyramidal cells via
activation of highly expressed 5-HT2A (and 5-HT7) receptors,
while 5-HT1A receptors are weakly coupled. With maturation,
5-HT1A receptor inhibition predominates over 5-HT2A function
(which becomes desensitized) as rats mature from early post-natal
period to adulthood.
In the anxiety model (Figure 1), under normal conditions
both 5-HT1A heteroreceptors on pyramidal and interneurons
are engaged, resulting in a balance between 5-HT1A-mediated
inhibition and dys-inhibition of pyramidal anxiety output neu-
rons. In mice with complete or nearly complete loss of 5-HT
(Figure 1, No 5-HT; Table 1, TPH2 or TPH1/2 double knock-
out), 5-HT1A inhibition of both pyramidal and interneurons
is predicted to be inactive and tonic interneuronal inhibition
of pyramidal neurons to predominate, thereby reducing anxi-
ety. Similarly, in mice expressing tetanus toxin in 5-HT neurons
there is a similar outcome of reduced anxiety since release of
5-HT is prevented, thus mimicking a lack of 5-HT. In models
where 5-HT is reduced but not entirely eliminated (Figure 1,
Low 5-HT; Table 1, Pet-1−/−, TPH-R439H knockin) the model
predicts that high affinity 5-HT1A receptors on interneurons
are preferentially engaged compared to those on pyramidal cells,
relieving GABA-mediated inhibition of pyramidal neurons in
the anxiety circuit, resulting in over-activation by even mild
stressors and an elevated anxiety phenotype (Holmes, 2008).
Similarly, over-expression of 5-HT1A autoreceptors also reduces
5-HT activity leading to a hyperactive anxiety circuit by prefer-
entially relieving inhibition of pyramidal neurons. On the other
hand, global knockout of all 5-HT1A receptors would allow for
hyper-activation of raphe neurons (due to absence of 5-HT1A
autoreceptor) and activation of pyramidal 5-HT2A receptors that
is not antagonized by pyramidal 5-HT1A receptors due to their
homologous and heterologous (5-HT2A-mediated) desensitiza-
tion, leading to increased anxiety. Pyramidal 5-HT2A receptors
may also actively suppress interneuronal GABA-mediated inhi-
bition via activation of protein kinase C (Bright and Smart,
2013). Consistent with a pro-anxiety role, mice lacking 5-HT2A
receptors display reduced anxiety that is reversed by Emx1-
driven cortical re-expression of 5-HT2A receptors (Weisstaub
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FIGURE 1 | Early post-natal 5-HT-PFC circuitry in anxiety models.
Shown are the components of the Raphe 5-HT-PFC circuit in animals during
the early post-natal period with no, low, normal or high levels of 5-HT
neurotransmission as indicated. Evidence from genetic mouse models
(Table 1) supports the importance of alterations in early post-natal circuitry
in generating the adult anxiety phenotype. The model shows 5-HT neurons
(orange) projecting to prefrontal cortex GABAergic interneurons (red) and
glutamatergic pyramidal neurons (green) with transmitter release illustrated
as small squares of the same colors. Although 5-HT neurons are shown
projecting separately to glutamatergic or GABAergic PFC neurons to
illustrate the different activities of these pathways, the same 5-HT neuron
may innervate both cells with different efficiency synapses or varicosities
(Bang et al., 2012). The presence of 5-HT1A (yellow), 5-HT2A (orange) and
GABA-A receptors (red) is shown, as well as the response in the target
neurons (clouds), stimulatory (+) or inhibitory (−). The effect of chronic
stress to stimulate pyramidal output is also indicated. It is postulated that
5-HT1A-mediated inhibition in the early post-natal period and perhaps adult
is greater in interneurons than pyramidal neurons and that increased
pyramidal neuronal activity triggers the anxiety phenotype, especially
during the early post-natal period.
et al., 2006). In addition, 5-HT2A receptor levels are increased in
early life stress and confer vulnerability to PFC hyperactivation
and anxiety (Benekareddy et al., 2010). Consistent with this
model, blockade of 5-HT2A receptors reduces anxiety induced by
post-natal SSRI, while post-natal blockade of 5-HT1A receptors
induces anxiety (Sarkar et al., 2013). Oppositely, early post-natal
CaMKIIα-driven rescue of 5-HT1A heteroreceptors on pyrami-
dal neurons in the 5-HT1A−/− background rescues the anxiety
phenotype (Gross et al., 2002). Early post-natal over-expression
of the 5-HT1A receptor in wild-type background also reduced
anxiety (Kusserow et al., 2004). On the other hand, CaMKIIα-
driven promoter suppression of 5-HT1A receptors on pyramidal
neurons (Richardson-Jones et al., 2011) may have had little effect
on anxiety due to the maintained inhibition by GABAergic neu-
rons. Thus, upon hyper-activation of the 5-HT system (High
5-HT, Figure 1), interneurons are predicted to be suppressed by
interneuronal 5-HT1A activation while 5-HT2A receptors are
predicted to respond to high 5-HT to activate pyramidal neu-
rons and desensitize pyramidal 5-HT1A and GABA signaling via
protein kinase C activation (Lembo and Albert, 1995; Wu et al.,
2002), leading to a hyper-activated pyramidal activity and an
anxiety phenotype.
The 5-HT1A receptor seems to play its major role in estab-
lishing the anxiety phenotype during the early post-natal period.
For example, CaMKIIα-driven promoter rescue of 5-HT1A recep-
tor expression in adult 5-HT1A−/− mice failed to restore normal
anxiety (Gross et al., 2002). Similarly, suppression of 5-HT1A
autoreceptor expression during the early post-natal period but
not adulthood elicited anxiety phenotype (Richardson-Jones
et al., 2010; Donaldson et al., 2014). This critical period for the
anxiety phenotype is associated with a developmental increase in
the activity of 5-HT1A receptors on pyramidal neurons during
this period (Beique et al., 2004). Suppressing pyramidal 5-HT1A
signaling by hyper-stimulating 5-HT2A receptors or by partially
reducing 5-HT activity leads to the hyper-activation of pyramidal
neurons to drive the anxiety phenotype. Anxiety in the 5-HT1A
knockout mouse appears to be resistant to the over-expression
in adulthood of 5-HT1A receptors in pyramidal cells, suggest-
ing that the predominance of 5-HT2A signaling prevents the
inhibitory function of 5-HT1A receptors. Interestingly early life
stress increases 5-HT1A RNA and 5-HT1A-induced potassium
current in the PFC, which may be a protective adaptation that
gradually diminishes with maturation to adulthood (Goodfellow
et al., 2009); while 5-HT2A receptor signaling is also increased
resulting in increased serotonin excitability of these neurons
(Benekareddy et al., 2010).
SEROTONIN-PFC CIRCUITRY MODEL IN THE DEPRESSION PHENOTYPE
Evidence from human imaging studies suggests that different sub-
populations of PFC neurons with different targets mediate anxi-
ety vs. depression behavior (Ressler and Mayberg, 2007; Krishnan
and Nestler, 2008; Savitz et al., 2009). In addition, early post-
natal development appears to be more important in the anxiety
phenotype (see above) compared to the depression phenotype.
Due to these differences, the serotonin circuitry model for depres-
sion involves similar components but is slightly different from the
anxiety model (Figure 2). First, opposite to anxiety, activation
of the pyramidal neuron is associated with reduced depression
and increased resilience. Second, we propose that the 5-HT2A
receptor is weakly active in the mature pyramidal neurons con-
trolling depression (Beique et al., 2004). Based on this the major
serotonergic control over the pyramidal neuron is through the
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FIGURE 2 | Adult 5-HT-PFC circuitry in depression models. Shown are
the components of the Raphe 5-HT-PFC circuit in adult animals with no,
low, normal or high levels of 5-HT neurotransmission as indicated. The
model shows 5-HT neurons (orange) projecting to prefrontal cortex
GABAergic interneurons (red) and glutamatergic pyramidal neurons (green)
with transmitter release illustrated as small squares of the same colors. The
presence of 5-HT1A (yellow), 5-HT2A (orange), AMPA-glutamate (green)
and GABA-A receptors (red) is shown, as well as the response in the target
neurons (clouds), stimulatory (+) or inhibitory (−). The effect of stress to
stimulate pyramidal output is also indicated. It is postulated that
5-HT1A-mediated inhibition in adulthood becomes predominant in
pyramidal neurons compared to interneurons, and that reduced activity of
target pyramidal neurons elicits depression during adulthood.
pyramidal 5-HT1A receptor that reduces activity, but is almost
saturated at normal 5-HT levels; at high 5-HT levels, 5-HT2A
or other excitatory receptors (5-HT4, 5-HT7) are recruited to
activate the pyramidal neurons and inactivate 5-HT1A signaling
(Hedlund et al., 2005; Lucas et al., 2007). Finally, in this model the
interneuronal 5-HT1A receptor is weakly active at normal 5-HT,
hence is a target of SSRI to enhance inhibition of the interneu-
ron thus further activating the pyramidal neuron. This model fits
with genetic models involving loss or increase in 5-HT levels, and
also with models of inhibition of adult 5-HT1A autoreceptor lev-
els. For example, the TPH2−/− and TPH2-R439H mutant that
reduce or eliminate 5-HT show depression phenotypes (Jacobsen
et al., 2012b; Mosienko et al., 2012; Sachs et al., 2013). Oppositely
suppression of 5-HT1A autoreceptors in adult to increase 5-HT
activity reduces depression behavior (Richardson-Jones et al.,
2010; Bortolozzi et al., 2012; Ferres-Coy et al., 2013) (Table 1).
Reduction of 5-HT1A autoreceptors in adulthood is associated
with accelerated and increased release of 5-HT at target areas
and enhanced SSRI-mediated behavioral improvement in depres-
sion and anxiety (Richardson-Jones et al., 2010; Bortolozzi et al.,
2012; Ferres-Coy et al., 2013). This is consistent with the negative
feedback role of 5-HT1A autoreceptors in regulating serotonergic
activity, and the need to down-regulate their expression for SSRI
to exert antidepressant activity (Albert and Francois, 2010).
However, the lack of effect on depression of lifetime suppres-
sion or over-expression of 5-HT1A autoreceptors (Richardson-
Jones et al., 2011; Audero et al., 2013) is not accounted for in
this model, suggesting that there may be early life adaptations
to compensate for the over- or under-expression of 5-HT1A
autoreceptors. Suppression of 5-HT1A heteroreceptors (using the
CAMKIIα promoter to target pyramidal neurons) would be pre-
dicted to increase pyramidal neuron firing and display an anxiety
phenotype rather than depression according to the model pro-
posed. Autoradiography of the hetero-receptor suppressed mouse
brain shows almost complete loss of cortical 5-HT1A binding
(Richardson-Jones et al., 2011), suggesting that in this model
CAMKIIα promoter is active in interneurons (as well as pyra-
midal cells), perhaps due to embryonic-initiated suppression.
Reduced interneuron 5-HT1A receptors would enhance interneu-
ron firing and inhibit pyramidal firing, leading to a depression
phenotype similar to the low or no 5-HT condition according to
the model (Figure 2). This result in Hetero-1A suppressed mice
suggests that 5-HT2A excitation upon loss of 5-HT1A heterore-
ceptors is insufficient to drive the anxiety phenotype or prevent
depression when the 5-HT1A autoreceptor is present.
Consistent with the above model for depression, there
is evidence of a 50% reduction in major depression of
calbindin-positive interneurons (which are 5-HT1A+ by in
situ hybridization de Almeida and Mengod, 2008) and not of
parvalbumin-positive interneurons (which lack 5-HT1A RNA)
(Rajkowska et al., 2007). In this case, serotonergic activation
would not reduce inhibitory interneuron feedback upon pyrami-
dal neurons, leading instead to a further inhibition of pyramidal
neurons, which could account for treatment resistant depression.
An aggressive phenotype is revealed in knockout models that
produce a strong reduction of 5-HT (e.g., TPH2 knockout),
but does not appear in 5-HT1A models (Table 1). Thus other
5-HT receptor subtypes may be involved, such as the 5-HT1B
receptor (Saudou et al., 1994). In humans, aggressive behavior
is more strongly associated with reduced 5-HT metabolites
in cerebrospinal fluid than is depression, and in combination
with depression, is a risk factor for suicide (Asberg, 1997). The
presence of aggressive or impulsive behavior with depression seen
in the “no 5-HT” (or very low 5-HT) condition, is consistent with
findings of reduced 5-HT synthesis in aggressive subjects (Booij
et al., 2010), and may increase likelihood of suicide attempt
(Mann, 2013).
OPTOGENETIC STUDIES OF THE SEROTONIN-PFC CIRCUITRY IN
DEPRESSION AND ANXIETY
Optogenetic studies have provided important data for the
formulation of serotonin-PFC circuitry models of anxiety and
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depression. For depression, specific optogenetic stimulation of rat
PFC pyramidal neurons projecting to the raphe increased kick-
ing frequency in the FST, indicating that these raphe-projecting
pyramidal neurons drive the “antidepressed” response in this
assay (Warden et al., 2012). These neurons are part of the long
negative feedback system involving pyramidal 5-HT1A receptors
that mediate inhibition of raphe activation by this projection
(Figure 2). Oppositely, a different set of PFC neurons project to
the lateral habenula to inhibit the kick response, inducing a “pro-
depressive” state. Thus, different populations of PFC neuronsmay
project to induce pro- or anti-depressant phenotypes, but it is not
known whether the 5-HT1A receptor is expressed in the lateral
habenula projecting neurons as it is in those that project to raphe.
If not, modulation of 5-HT1A receptor activity in PFC would
target the antidepressant response in a specific way.
Other studies suggest a similar circuitry to that proposed for
PFC may exist in the hippocampal CA1 region (Varga et al.,
2009). Optogenetic stimulation of raphe projections inhibits CA1
pyramidal neurons via 5-HT1A receptors on these neurons; in
addition, raphe projections innervate interneurons activating
them via 5-HT3 receptors, but also inhibiting them via 5-HT1A
receptors. Further studies are needed to examine the specific con-
tribution of 5-HT neurons to these actions. These studies suggest
that the serotonin circuitry model that we propose for the PFC
may be replicated in part in other brain regions such as the
hippocampus that mediate serotonin-regulated behavioral and
cognitive actions.
TRANSCRIPTIONAL MODIFIERS OF 5-HT1A RECEPTOR
EXPRESSION IN ANXIETY AND DEPRESSION
Given the role of altered serotonin regulation in these genetic
models of mouse behavior, what insights can be made into more
effective treatment of human depression and anxiety by targeting
different populations of the 5-HT1A receptor? One approachmay
be to “reset” the transcriptional regulation of the 5-HT1A recep-
tor gene (Albert, 2012). The 5-HT1A receptor gene is regulated
by a number of identified transcription factors, some of which
show cell-specificity. For example, PET-1 is required for 5-HT1A
receptor expression specifically in serotonin neurons due to its
exclusive expression in these neurons, although it is not required
in adult neurons (Liu et al., 2010). Other transcription factors that
may dynamically regulate 5-HT1A receptors in the brain include
Deaf1 and Freud-1/Freud-2 repressor proteins.
THE 5-HT1A C(-1019)G POLYMORPHISM AND DEAF1
The human 5-HT1A C(-1019)G polymorphism (rs6295) is
located upstream of the basal promoter in a palindromic DNA
element that is recognized at the C-allele by transcription fac-
tors Deaf1 and Hes1/5 (Lemonde et al., 2003; Jacobsen et al.,
2008). Hes1/5 expression in brain is restricted to early develop-
mental neural progenitors and is switched off as they differentiate
into mature neurons. Hes1 mediates stronger repression than
Hes5, and gene knockout of Hes1 in mice results in premature
embryonic over-expression of 5-HT1A receptors in the midbrain
and hindbrain (Jacobsen et al., 2008). Deaf1 is expressed in the
brain throughout development and in adulthood. Deaf1 represses
5-HT1A receptor expression in raphe cells (Lemonde et al., 2003),
yet enhances its transcription in some non-serotonergic cells
(Czesak et al., 2006). Importantly Deaf1 is strongly expressed in
several regions that are enriched on 5-HT1A receptors, especially
raphe nuclei, PFC and hippocampal CA1 pyramidal neurons
(Lemonde et al., 2003; Szewczyk et al., 2009). In Deaf1−/− mice,
a 50% upregulation of 5-HT1A autoreceptors was observed, with
a 30% reduction in 5-HT1A expression in PFC but no change
in hippocampus, consistent with a neuron-specific regulation by
Deaf1 (Czesak et al., 2012). Activation of Deaf1 could have benefi-
cial effects: reducing 5-HT1A autoreceptor expression to enhance
serotonergic activity while increasing 5-HT1A heteroreceptors in
PFC. It is unclear however, whether 5-HT1A receptors on pre-
frontal pyramidal neurons, interneurons or both are affected by
Deaf1. It is unclear whether Deaf1 is also expressed in interneu-
rons. In septal SN-48 cells, which express 5-HT1A receptors and
are GABAergic (Charest et al., 1993), Deaf1 enhances 5-HT1A
receptor transcription (Czesak et al., 2006), suggesting that it
may have enhancer activity on 5-HT1A receptors in interneurons
but this remain to be addressed. Deaf1 is expressed in 5-HT1A+
pyramidal neurons of the human PFC, particularly lamina II/III
(Szewczyk et al., 2009). In antidepressant-free female depressed
subjects Deaf1 and 5-HT1A protein levels were decreased, con-
sistent with reduced 5-HT1A-mediated inhibition of pyramidal
neurons in depression that may be driven by reduced Deaf1
expression (Szewczyk et al., 2009). Interestingly, estrogen induces
Deaf1 protein levels in cultured neuronal cells (Adeosun et al.,
2012), which could underlie a more prominent role in female
depression. Although activation of Deaf1 could be beneficial in
treatment of anxiety and depression, Deaf1 may also have benefi-
cial actions on the immune system including enhancing responses
to peripheral tissue antigens and to viral antigens (Yip et al., 2009;
Ordureau et al., 2013).
The 5-HT1A C(-1019)G polymorphism (rs6295) appears to
alter 5-HT1A receptor expression in humans and is associated
with major depression, suggesting a role for Deaf1 in human
depression. In particular, this polymorphism has been associ-
ated with major depression (Lemonde et al., 2003; Kishi et al.,
2013), bipolar depression (Kishi et al., 2013), completed sui-
cide (Wasserman et al., 2006) (although not suicidal ideation or
attempt) and anxiety disorders as well as reduced response to SSRI
and antipsychotics that target 5-HT1A receptors (Le François
et al., 2008; Newman-Tancredi and Albert, 2012). In one study,
the strongest association was seen in patients with depression
and comorbid anxiety (Molina et al., 2011). Adult stress, but not
early life stress, in combination with the risk G-allele increases the
association with increased stress reactivity, depression and sui-
cide (Wasserman et al., 2006; Benedetti et al., 2011; Mekli et al.,
2011; Lebe et al., 2013). However in a larger study of normal sub-
jects no such associations were found (Chipman et al., 2010).
PET imaging studies in non-medicated depressed subjects show
that the GG genotype is associated increase 5-HT1A receptors
in raphe, with little change in post-synaptic regions (Hesselgrave
and Parsey, 2013). Others groups have reported decreases in post-
synaptic 5-HT1A receptors in cortex, hippocampus and amygdala
in depression or anxiety (Akimova et al., 2009). Treatment with
antidepressants leads to a reduction in raphe 5-HT1A bind-
ing potential (Gray et al., 2013), and the GG-genotype ha been
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associated with reduced response or resistance to antidepressant
treatment. Taken together these results implicate dys-regulation
of 5-HT1A gene transcription in predisposition to depression
and related disorders, and in reducing response to antidepressant
treatment.
FREUD-1/FREUD-2 REPRESSION OF THE 5-HT1A PROMOTER
Freud-1 was identified as a strong repressor of 5-HT1A autore-
ceptors on raphe neurons, but also represses the receptor in
non-serotonergic neurons (Ou et al., 2003). Freud-1 is strongly
expressed in raphe, PFC and hippocampus and colocalized with
5-HT1A receptors. Freud-1 appears to be stress-sensitive, as
chronic stress in rats reduced Freud-1 levels in PFC while increas-
ing 5-HT1A receptor levels, perhaps representing a compensatory
adaptation to the stress (Iyo et al., 2009). In humans, Freud-1
and 5-HT1A protein levels were reduced in PFC of depressed
subjects particular younger subjects, suggesting an early role
(Szewczyk et al., 2010). While Freud-1 protein was reduced,
Freud-1 is inhibited by calcium-CaMK and could downregulate
5-HT1A expression in response to reduced calcium levels (Ou
et al., 2003). Since CaMKII is primarily expressed in pyrami-
dal neurons, calcium-mediated inactivation of Freud-1 may be
more specific to these neurons compared to interneurons, leading
to calcium-mediated up-regulation of 5-HT1A heteroreceptors
specifically in pyramidal neurons.
Freud-2 is a homologue of Freud-1 and binds to a site adjacent
to Freud-1 to repress 5-HT1A receptor expression (Hadjighassem
et al., 2009, 2011). Unlike Freud-1, Freud-2 sparsely expressed in
the raphe, but is strongly expressed in PFC where it is colocal-
ized with 5-HT1A receptors and a trend for reduced Freud-2 in
the PFC of depressed patients was observed (Hadjighassem et al.,
2009). Down-regulation of Freud-2 may be beneficial in depres-
sion to increase 5-HT1A expression in pyramidal neurons and
enhance their firing activity.
GLUCOCORTICOID-MEDIATED REPRESSION OF THE 5-HT1A PROMOTER
The 5-HT1A receptor gene is repressed by glucocorticoids, par-
ticular in the hippocampus which expresses both high and
low affinity glucorticoid receptors (MR and GR, respectively).
Together the MR/GR complex represses 5-HT1A promoter at a
negative GRE, as well as indirectly by suppressing Sp1-induced
promoter activity (Meijer et al., 2000; Ou et al., 2001). Studies
in rodents have shown that post-synaptic 5-HT1A receptors are
impacted by stress or corticosteroids. 5-HT1A receptors in the
rodent hippocampus (Chalmers et al., 1994; Lopez et al., 1998;
van Riel et al., 2003, 2004) and basolateral anterior, basolat-
eral ventral and basomedial amygdaloid nuclei as well as the
hypothalamus (Vicentic et al., 2006) are desensitized or down-
regulated after chronic stress or corticosterone administration.
In addition, socially stressed tree shrews have reduced 5-HT1A
receptor levels in the posterior cingulate cortex, parietal cor-
tex, hippocampus, and PFC. These stress-induced effects are
prevented by adrenalectomy (Chalmers et al., 1994) and sug-
gest a key role of stress in 5-HT1A receptor dys-regulation.
Similarly, SSRI induced reduction in 5-HT1A autoreceptor bind-
ing is observed in chronic stress models but not naïve ani-
mals (Rainer et al., 2012). In human social anxiety, 5-HT1A
receptors are reduced in amygdala and cingulate cortex and
negatively correlated with plasma cortisol levels, consistent
with glucocorticoid-induced down-regulation of the receptor
in anxiety-associated brain regions (Lanzenberger et al., 2007,
2010).
Targeting elevated activity of the hypothalamo-pituitary axis
or glucocorticoid signaling in anxiety and depression may have
several beneficial effects via alteration in the serotonin sys-
tem via up-regulation of 5-HT1A heteroreceptors, including a
preferential effect to enhance hippocampal 5-HT1A receptors
which are the most sensitive to glucocorticoids (Meijer and de
Kloet, 1998). In models with chronic elevation of glucocorti-
coids, glucocorticoid inhibition would induce a more general
up-regulation of 5-HT1A heteroreceptors throughout the brain,
although the specificity for pyramidal vs. interneuron 5-HT1A
receptors remain to be clarified.
CONCLUSION: INTEGRATED MODEL OF 5-HT-PREFRONTAL
CIRCUITRY IN ANXIETY AND DEPRESSION
Recent and increasingly sophisticated mouse genetic models have
resulted in a more precise dissection of the roles of 5-HT activ-
ity, and 5-HT1A autoreceptors vs. heteroreceptors in anxiety-
and depression-like behavior in rodents. These models have been
examined for their anxiety and depression-like behavioral pheno-
types and have shown that (see Table 1):
• Alteration in serotonin genes (5-HT1A, 5-HTT, TPH2) pro-
duces an anxiety and/or depression phenotype.
• Early post-natal modulation of the 5-HT system can produce
lifelong changes in anxiety/stress reactivity.
• Both pre- and post-synaptic 5-HT1A receptors contribute to
anxiety and depression phenotypes, often in opposite ways.
• High (5-HT1A autoreceptor or 5-HTT knockout) or low
(TPH2 or Pet-1 knockout) 5-HT neurotransmission can result
in anxiety phenotype; very low 5-HT results in anxiety and
aggressive behavior.
• Downregulation of 5-HT1A autoreceptor accelerates and
enhances SSRI action (Richardson-Jones et al., 2010;
Bortolozzi et al., 2012).
• 5-HT1A receptors are required for neurogenic and anti-anxiety
actions of chronic SSRI treatment (Santarelli et al., 2003).
In order to begin to integrate results obtained from these stud-
ies, we have proposed a model of 5-HT-PFC circuitry that takes
into account the presence of 5-HT1A heteroreceptors on both
interneurons and pyramidal neurons (Figures 1, 2). Themodel of
anxiety considers that early post-natal circuitry is critical, while
the depression model propose the role of a different population
of PFC neurons during later development. The model postulates
that behavioral phenotype shifts as serotonin activity increases:
• No or very low 5-HT: depression and aggression phenotype
(high risk for suicidal behavior).
• Low 5-HT: anxiety (early post-natal) and depression
(adolescent-adult).
• Normal 5-HT: no anxiety, aggression, and depression.
• High 5-HT: anxiety (early post-natal) phenotype.
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Predictions of the model include the co-morbidity of anxiety
and depression (at low 5-HT), alternation between depressed and
anxious states (low to very low 5-HT), as well as the effective-
ness of SSRI on both anxiety and depression (increasing 5-HT
from very low or low to normal). Additionally, 5-HT1A-mediated
inhibition of interneuronal firing is predicted to play a key role
in activation of PFC pyramidal neurons that could either induce
anxiety (during early post-natal period) or reduce depression in
adult. The importance of this circuit in behavior remains unclear,
in part because selective modulation of 5-HT1A receptors in PFC
interneurons has not been achieved.
The specific role of interneuronal 5-HT1A receptors in reg-
ulating pyramidal neurons has been studied electrophysiologi-
cally, however their role in behavior has yet to be specifically
addressed. An understanding of the role of both pyramidal and
interneuronal 5-HT1A heteroreceptors in behavior and how their
expression may change in human depression and anxiety may
provide important insights into targeting distinct populations of
5-HT1A heteroreceptors by transcriptional modifiers. To date,
interneuron-specific expression of CRE for conditional knock-
out is limited to interneuron subtype (calbindin, parvalbumin,
or somatostatin), but not specific brain regions. Systemic admin-
istration of 5-HT1A agonists, such as DPAT, activates pyrami-
dal firing preferential through the interneuronal pathway, but
also inhibits 5-HT neurons via 5-HT1A autoreceptor activation
(Llado-Pelfort et al., 2012). However, new generation 5-HT1A
agonist show promise in targeting post-synaptic 5-HT1A recep-
tors, and may prove selective to interneurons (Llado-Pelfort et al.,
2010), and more effective as antidepressants than less selec-
tive 5-HT1A agonists such as buspirone (Rush et al., 2009).
Alternately, pharmacological modification of transcription fac-
tors that show regions specific activity on 5-HT1A transcription,
such as Deaf1 or MR, may provide new approaches to treat
depression or augment antidepressant activity.
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